Award of share options
July 31 2007 - 12:41PM
UK Regulatory
RNS Number:2486B
Lipoxen PLC
31 July 2007
Lipoxen Plc ("Lipoxen" or "the Company")
Award of share options
London, UK, 31 July, 2007 - Lipoxen plc, a biopharmaceutical company
specialising in the development of high value differentiated biologicals,
vaccines and oncology drugs, today announces that Colin Hill, Finance Director
of the Company has been awarded a total of 400,000 share options in the Company
exercisable at a price of 47.75 pence per share and vesting as noted below:
200,000 options exercisable at 47.75 pence per share vesting immediately
200,000 options exercisable at 47.75 pence per share vesting on 31 July 2008
Enquiries:
Lipoxen PLC
M. Scott Maguire, CEO +44 (0)20 7691 3583
Grant Thornton Corporate Finance
Philip J Secrett +44 (0)20 7383 5100
Citigate Dewe Rogerson
Yvonne Alexander +44 (0)20 7638 9571
This information is provided by RNS
The company news service from the London Stock Exchange
END
RDSSDUFMFSWSEDW
Lipoxen (LSE:LPX)
Historical Stock Chart
From Aug 2024 to Sep 2024
Lipoxen (LSE:LPX)
Historical Stock Chart
From Sep 2023 to Sep 2024